Luspatercept,epoetin alfa
Bms
['lusp']
luspatercept poised to become a new first-line standard of care for transfusion-dependent, lower-risk myelodysplastic syndromes #asco23 
Chief MedOnc @SylvesterCancer @UnivMiami. Improving access to cancer meds in LMICs. Editor-in-Chief @JCOGO_ASCO, Board Member @UICC - co-chair #ATOMcoalition